DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Genes & Development

• Publication date

  2011-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/gad.2034211PMID 21498570PMCID PMC3078706
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles

  2011influential reference
• A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

  2011cited by this paper
• Down Syndrome: From Understanding the Neurobiology to Therapy

  2010cited by this paper
• LATS tumor suppressor: A new governor of cellular homeostasis

  2010cited by this paper
• Gene Network Disruptions and Neurogenesis Defects in the Adult Ts1Cje Mouse Model of Down Syndrome

  2010cited by this paper
• Dyrk1A Overexpression Inhibits Proliferation and Induces Premature Neuronal Differentiation of Neural Progenitor Cells

  2010cited by this paper
• Senescence in tumours: evidence from mice and humans

  2010cited by this paper
• Function and regulation of Dyrk1A: towards understanding Down syndrome

  2009cited by this paper
• Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome

  2009cited by this paper
• Generation and analysis of multidimensional protein identification technology datasets.

  2009influential reference
• Cell cycle, CDKs and cancer: a changing paradigm

  2009cited by this paper
• Down syndrome suppression of tumor growth and the role of the calcineurin inhibitor DSCR1

  2009cited by this paper
• Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.

  2009cited by this paper
• Conserved functions of the pRB and E2F families

  2008cited by this paper
• Mip/LIN-9 Regulates the Expression of B-Myb and the Induction of Cyclin A, Cyclin B, and CDK1*

  2007cited by this paper
• The Inhibition of Polo Kinase by Matrimony Maintains G2 Arrest in the Meiotic Cell Cycle

  2007cited by this paper
• The SynMuv genes of Caenorhabditis elegans in vulval development and beyond.

  2007cited by this paper
• Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice

  2007cited by this paper
• Genomic profiling and expression studies reveal both positive and negative activities for the Drosophila Myb MuvB/dREAM complex in proliferating cells.

  2007influential reference
• LINC, a Human Complex That is Related to pRB-Containing Complexes in Invertebrates Regulates the Expression of G2/M Genes

  2007influential reference
• Specific In Vivo Roles for E2Fs in Differentiation and Development

  2007cited by this paper
• The human synMuv‐like protein LIN‐9 is required for transcription of G2/M genes and for entry into mitosis

  2007cited by this paper
• Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.

  2007influential reference
• Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex

  2007cited by this paper
• The selectivity of protein kinase inhibitors: a further update.

  2007cited by this paper
• Cell Cycle Genes Are the Evolutionarily Conserved Targets of the E2F4 Transcription Factor

  2007cited by this paper
• Interweaving the Cell Cycle Machinery with Cell Differentiation

  2007cited by this paper
• Proteomic analysis by multidimensional protein identification technology.

  2006cited by this paper
• Some C. elegans class B synthetic multivulva proteins encode a conserved LIN-35 Rb-containing complex distinct from a NuRD-like complex

  2006cited by this paper
• The retinoblastoma gene family in cell cycle regulation and suppression of tumorigenesis.

  2006cited by this paper
• Pocket proteins and cell cycle control

  2005cited by this paper
• Cell-cycle control in Caenorhabditis elegans: how the worm moves from G1 to S

  2005cited by this paper
• The E2F transcriptional network: old acquaintances with new faces

  2005cited by this paper
• Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.

  2004influential reference
• Identification of a Drosophila Myb-E2F2/RBF transcriptional repressor complex.

  2004cited by this paper
• Cell cycling through development

  2004cited by this paper
• Molecular signature of oncogenic ras-induced senescence

  2004cited by this paper
• Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2α

  2004cited by this paper
• Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

  2004cited by this paper
• Glycogen Synthase Kinase 3 Phosphorylates RBL2/p130 during Quiescence

  2004cited by this paper
• G1 cell-cycle control and cancer

  2004cited by this paper
• A common set of gene regulatory networks links metabolism and growth inhibition.

  2004influential reference
• Hitting their targets: an emerging picture of E2F and cell cycle control.

  2004cited by this paper
• Inhibition of oncogenic transformation by mammalian Lin‐9, a pRB‐associated protein

  2004cited by this paper
• Dyrk1A Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice

  2002cited by this paper
• Role for a Drosophila Myb-containing protein complex in site-specific DNA replication

  2002cited by this paper
• Role for YakA, cAMP, and protein kinase A in regulation of stress responses of Dictyostelium discoideum cells.

  2002cited by this paper
• E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.

  2002cited by this paper
• E 2 F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC 1 / mSin 3 B corepressor complex

  2002cited by this paper
• Cycling through development in Drosophila and other metazoa

  2001cited by this paper
• The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.

  2001cited by this paper
• To cycle or not to cycle: a critical decision in cancer

  2001cited by this paper
• Efficient eukaryotic expression system for authentic human sex hormone-binding globulin.

  2001cited by this paper
• Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.

  2001cited by this paper
• Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

  2000cited by this paper
• Specificity Determinants of Substrate Recognition by the Protein Kinase DYRK1A*

  2000cited by this paper
• Creation of human tumour cells with defined genetic elements

  1999cited by this paper
• YakA, a protein kinase required for the transition from growth to development in Dictyostelium.

  1998cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Dyrk, a Dual Specificity Protein Kinase with Unique Structural Features Whose Activity Is Dependent on Tyrosine Residues between Subdomains VII and VIII (*)

  1996cited by this paper
• The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state

  1996cited by this paper
• minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila.

  1995cited by this paper
• Molecular oncology

  1991cited by this paper

• A Unique Patient Stratification Method Combined with a Machine Learning Approach Identifies Novel Genetic Susceptibility and Protective Factors for Severe COVID-19 in a Hungarian Population

  2026cites this paper
• Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.

  2026cites this paper
• The role of Goldilocks protein kinase DYRK1A in embryonic development.

  2025cites this paper
• The DREAM complex links somatic mutation, lifespan, and disease

  2025cites this paper
• Targeting DNA damage in ageing: towards supercharging DNA repair

  2025cites this paper
• Induction of cellular senescence by androgen receptor agonist or antagonist is mediated via two novel common DYRK1A-DREAM and cyclin G2 signaling pathways in castration-resistant prostate cancer

  2025cites this paper
• Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer’s Diseases

  2025cites this paper
• Understanding Tumor Dormancy: from Experimental Models to Mechanisms and Therapeutic Strategies

  2025cites this paper
• STAG2 cohesin cooperates with DREAM to maintain quiescence and suppress tumourigenesis in the urothelium

  2025cites this paper
• Chaperone-mediated autophagy directs a dual mechanism to balance premature senescence and senolysis to prevent intervertebral disc degeneration

  2025cites this paper
• OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer

  2025cites this paper
• N-Acetyl Cysteine as a promising therapeutic approach in ovarian cancer: potential and perspectives

  2025cites this paper
• E6AP is essential for the proliferation of HPV-positive cancer cells by preventing senescence

  2025cites this paper
• Targeting Genome Stability to Mitigate Human Aging and Disease.

  2025cites this paper
• Network Modeling Predicts How DYRK1A Inhibition Promotes Cardiomyocyte Cycling after Ischemic/Reperfusion Injury

  2025cites this paper
• Chromothripsis-associated chromosome 21 amplification orchestrates transformation to blast-phase MPN through targetable overexpression of DYRK1A

  2025cites this paper
• A non‐canonical role for the tyrosyl tRNA synthetase: YARS regulates senescence induction and escape and controls the transcription of LIN9

  2025cites this paper
• Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities

  2025cites this paper
• A safe haven for cancer cells: tumor plus stroma control by DYRK1B

  2025cites this paper
• Human Cytomegalovirus Dysregulates Cellular Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases and Sonic Hedgehog Pathway Proteins in Neural Astrocyte and Placental Models

  2024cites this paper
• DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity

  2024cites this paper
• The p21CIP1-CDK4-DREAM axis is a master regulator of genotoxic stress-induced cellular senescence

  2024cites this paper
• Regulation of Drosophila brain development and organ growth by the Minibrain/Rala signaling network

  2024cites this paper
• Increased dosage of DYRK1A leads to congenital heart defects in a mouse model of Down syndrome

  2024cites this paper
• RBL2 represses the transcriptional activity of Multicilin to inhibit multiciliogenesis

  2024cites this paper
• Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway

  2024cites this paper
• miR-96-5p expression is sufficient to induce and maintain the senescent cell fate in the absence of stress

  2024cites this paper
• From Churchill to Elephants: The Role of Protective Genes against Cancer

  2024cites this paper
• Research progress on the antitumor effects of harmine

  2024cites this paper
• Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs

  2024influential citation
• Emerging role of cellular senescence in normal lung development and perinatal lung injury

  2024cites this paper
• Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy

  2024cites this paper
• DYRK1B blockade promotes tumoricidal macrophage activity in pancreatic cancer

  2024cites this paper
• Dyrk1a is required for craniofacial development in Xenopus laevis.

  2024cites this paper
• Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.

  2024cites this paper
• The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence.

  2024cites this paper
• Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment

  2024cites this paper
• Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes

  2024cites this paper
• THE FAM53C/DYRK1A axis regulates the G1/S transition of the cell cycle

  2024cites this paper
• Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells

  2024cites this paper
• Genetic origins, regulators, and biomarkers of cellular senescence.

  2024cites this paper
• Insights from the protein interaction Universe of the multifunctional “Goldilocks” kinase DYRK1A

  2023cites this paper
• Regulation of CMGC kinases by hypoxia

  2023cites this paper
• Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

  2023cites this paper
• Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis

  2023influential citation
• Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion

  2023cites this paper
• RBL2 represses the transcriptional activity of Multicilin to inhibit multiciliogenesis

  2023cites this paper
• Dose imbalance of DYRK1A kinase causes systemic progeroid status in Down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels

  2023cites this paper
• Congenital heart defects in Down syndrome are caused by increased dosage of DYRK1A

  2023cites this paper
• The DREAM complex functions as conserved master regulator of somatic DNA-repair capacities

  2023cites this paper
• Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex

  2023cites this paper
• Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer.

  2023cites this paper
• Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders

  2023cites this paper
• Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research

  2023cites this paper
• Quiescent Cancer Cells—A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse

  2023cites this paper
• Understanding cellular senescence: pathways involved, therapeutics and longevity aiding

  2023cites this paper
• Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies

  2023cites this paper
• Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution

  2023cites this paper
• A cell cycle centric view of tumour dormancy

  2023cites this paper
• DREAM a little dREAM of DRM: Model organisms and conservation of DREAM‐like complexes

  2023cites this paper
• PCLAF-DREAM drives alveolar cell plasticity for lung regeneration

  2023cites this paper
• The two plant-specific DREAM components FLIC and FLAC repress floral transition in Arabidopsis

  2023cites this paper
• The YARS Tyrosyl tRNA Synthetase Regulates Senescence Induction and Escape Through the Transcriptional Control of LIN9, a Member of the DREAM Complex

  2023cites this paper
• DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells

  2023cites this paper
• Cell cycle exits and U-turns: Quiescence as multiple reversible forms of arrest

  2023cites this paper
• The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target

  2022cites this paper
• Regeneration of Pancreatic β-Cells for Diabetes Therapeutics by Natural DYRK1A Inhibitors

  2022cites this paper
• Principles of dormancy evident in high-grade serous ovarian cancer

  2022cites this paper
• Inhibition of DYRK1a Enhances Cardiomyocyte Cycling After Myocardial Infarction

  2022cites this paper
• A reassessment of Jackson’s checklist and identification of two Down syndrome sub-phenotypes

  2022cites this paper
• The role of cellular senescence and SASP in tumour microenvironment

  2022cites this paper
• A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer

  2022cites this paper
• The MuvB complex binds and stabilizes nucleosomes downstream of the transcription start site of cell-cycle dependent genes

  2022cites this paper
• Chromatin Dynamics During Entry to Quiescence and Compromised Functionality in Cancer Cells.

  2022cites this paper
• The MuvB complex safeguards embryonic stem cell identity through regulation of the cell cycle machinery

  2022cites this paper
• The Omnipresence of DYRK1A in Human Diseases

  2022cites this paper
• Alterations of presynaptic proteins in autism spectrum disorder

  2022cites this paper
• Transcriptome analysis of the binucleate ciliate Tetrahymena thermophila with asynchronous nuclear cell cycles

  2022cites this paper
• Tumor cell dormancy: Molecular mechanisms, and pharmacological approaches to target dormant cells for countering tumor

  2022cites this paper
• Coordinating gene expression during the cell cycle.

  2022cites this paper
• A slow-cycling/quiescent cells subpopulation is involved in glioma invasiveness

  2022cites this paper
• Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells

  2022influential citation
• Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family

  2022cites this paper
• Structure and function of MuvB complexes

  2022cites this paper
• Inhibition of DYRK1A, via histone modification, promotes cardiomyocyte cell cycle activation and cardiac repair after myocardial infarction

  2022cites this paper
• DREAM Interrupted: Severing LIN-35-MuvB association in Caenorhabditis elegans impairs DREAM function but not its chromatin localization.

  2022cites this paper
• The human antigen R as an actionable super-hub within the network of cancer cell persistency and plasticity

  2022cites this paper
• The Hippo Signaling Pathway in Cancer: A Cell Cycle Perspective

  2021cites this paper
• DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells

  2021cites this paper
• Cell cycle regulation by complex nanomachines

  2021cites this paper
• Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.

  2021cites this paper
• The MuvB complex binds and stabilizes nucleosomes downstream of the transcription start site of cell-cycle dependent genes

  2021cites this paper
• Global phosphoproteomics reveals DYRK1A regulates CDK1 activity in glioblastoma cells

  2021cites this paper
• Progesterone Receptors Promote Quiescence & Ovarian Cancer Cell Phenotypes via DREAM in p53-Mutant Fallopian Tube Models.

  2021influential citation
• Autophagy and Cancer Dormancy

  2021cites this paper
• Targeting DYRK1A/B kinases to modulate p21‐cyclin D1‐p27 signalling and induce anti‐tumour activity in a model of human glioblastoma

  2021cites this paper
• Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence

  2021cites this paper
• Oncogenic B-Myb Is Associated With Deregulation of the DREAM-Mediated Cell Cycle Gene Expression Program in High Grade Serous Ovarian Carcinoma Clinical Tumor Samples

  2021cites this paper
• Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells

  2021cites this paper
• PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis

  2021cites this paper